Healthcare Realty Trust Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Healthcare Realty Trust Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.18B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.27B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.34B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $932.64M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $534.82M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $499.63M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $692.04M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $696.43M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $613.99M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $460.93M | Feb 19, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.22M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $19.16M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $17.45M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $13.71M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $10.29M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $7.37M | Mar 1, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($246.07M) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($654.49M) | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | ($278.26M) | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $40.90M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $66.66M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $72.20M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $30.15M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $213.46M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $63.92M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $45.91M | Feb 19, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $123.65M | Feb 20, 2018 |
| FY2017 | Dec 31, 2016 | $101.92M | Feb 20, 2018 |
| FY2017 | Dec 31, 2015 | $93.58M | Feb 20, 2018 |
| FY2016 | Dec 31, 2014 | $83.07M | Feb 21, 2017 |
| FY2015 | Dec 31, 2013 | $66.26M | Feb 22, 2016 |
| FY2012 | Dec 31, 2012 | $10.06M | Mar 1, 2013 |
| FY2012 | Sep 30, 2012 | $11.23M | Mar 1, 2013 |
| FY2012 | Jun 30, 2012 | ($1.56M) | Mar 1, 2013 |
| FY2012 | Mar 31, 2012 | $10.70M | Mar 1, 2013 |
| FY2012 | Dec 31, 2011 | $11.73M | Mar 1, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $457.10M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $501.62M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $499.82M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $272.75M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $232.63M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $470.09M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $340.39M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $337.40M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $307.54M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $203.70M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.21B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $10.65B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $12.64B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $13.85B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $4.26B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $6.79B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $6.64B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $6.19B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $6.45B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $3.75B | Feb 20, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.53B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.35B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.71B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $6.17B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.07B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.56B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $3.21B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.85B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $3.08B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $1.96B | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.62B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.23B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $6.82B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $7.57B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.19B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.17B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $3.36B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $3.26B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $3.28B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $1.69B | Feb 20, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Feb 19, 2025 |
| FY2024 | Dec 31, 2023 | $250.53M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $223.20M | Feb 16, 2024 |
| FY2024 | Jul 20, 2022 | $247.04M | Feb 19, 2025 |
| FY2022 | Dec 31, 2021 | $3.49M | Mar 1, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | ($742.06M) | Feb 25, 2014 |
| FY2013 | Dec 31, 2012 | ($633.72M) | Feb 25, 2014 |
| FY2012 | Dec 31, 2011 | ($467.25M) | Mar 1, 2013 |
| FY2011 | Dec 31, 2010 | ($310.19M) | Mar 27, 2012 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.17M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $68.92M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $25.70M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $60.96M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $13.18M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $115.41M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $32.71M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $126.22M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $100.36M | Feb 19, 2019 |
| FY2018 | Dec 31, 2016 | $11.23M | Feb 19, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.91B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.66B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $4.99B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $5.35B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.80B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.03B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $2.75B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.54B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $2.78B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $1.77B | Feb 20, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 19, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 19, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 351.60M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 350.53M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | 380.96M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 380.59M | Feb 16, 2024 |
| FY2024 | Jul 20, 2022 | 228.86M | Feb 19, 2025 |
| FY2022 | Dec 31, 2021 | 150.46M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 218.58M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 216.45M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 205.27M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | 204.89M | Feb 19, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $386.92M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $457.85M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $472.24M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $283.71M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $175.46M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $162.56M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $256.12M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $252.65M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $207.09M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $159.17M | Feb 19, 2019 |